News & Updates

Esketamine outperforms quetiapine in head-to-head depression trial
Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023 byJairia Dela Cruz

In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.

Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023
Remnant cholesterol ups GDM risk in pregnant women
Remnant cholesterol ups GDM risk in pregnant women
29 Oct 2023

Increased levels of remnant cholesterol (RC) appear to elevate the risk of gestational diabetes mellitus (GDM), independent of traditional risk factors, suggests a study. Moreover, pregnant women with high prepregnancy body mass index (BMI), high triglyceride (TG), and high RC levels are at greater GDM risk.

Remnant cholesterol ups GDM risk in pregnant women
29 Oct 2023
Antiviral therapy safe, effective in children with immune-tolerant HBV infection
Antiviral therapy safe, effective in children with immune-tolerant HBV infection
28 Oct 2023